Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 66584347 | HCID 66584347 | — |
| Reactant | 2-(2-Chloropyrimidin-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol | HCID 86670348 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 86670442 | HCID 86670442 | — |
| Product | HCID 86670443 | HCID 86670443 | — |
Reaction Steps
In a 50-mL sealed vial, a mixture of (S)-3-(prop-1-yn-1-yl)-1-(thiophen-2-ylsulfonyl)piperazine (40 mg, 0.148 mmol), 2-(2-chloropyrimidin-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-ol (41.5 mg, 0.148 mmol), and triethylamine (30.9 μl, 0.222 mmol) in dioxane was heated to 100° C. for 16 h. Afterwards, the mixture was concentrated and the crude material was purified via column chromatography (about 40 g silica gel, 0% to 10% MeOH in CH2Cl2) to give the racemate of 1,1,1,3,3,3-hexafluoro-2-(2-((2S)-2-(1-propyn-1-yl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)-5-pyrimidinyl)-2-propanol (18 mg) and 1,1,1,3,3,3-hexafluoro-2-(2-((2R)-2-(1-propyn-1-yl)-4-(2-thiophenylsulfonyl)-1-piperazinyl)-5-pyrimidinyl)-2-propanol (18 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08431563B2 |
|---|
| Source dataset | uspto-grants-2013_04 |
|---|
| ORD ID | ord-2192ccca44454974a9b66c319d7b37aa |
|---|
| Source note | uspto-grants-2013_04 |
|---|